
Industry Insights: Early Safety and Human-Relevant Models Gain Strategic Weight

Ncardia and LUMC Develop Automated Human Cardiac Microtissue Platform
Scaling Human Biology: Mariana Argenziano's Impact on iPSC Manufacturing
Human-Relevant Discovery Begins With the Model: A Conversation With Shushant Jain
.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne Holt
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug Discovery
